[Development of HCV vaccine].
Abe
Takayuki
T
Research Center for Emerging Infectious Diseases, Research Institute for Microbial Diseases, Osaka University.
Moriishi
Kohji
K
Matsuura
Yoshiharu
Y
D000818:Animals; D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000378:metabolism / Q000502:physiology; D005822:Genetic Vectors; D016174:Hepacivirus / Q000472:pathogenicity; D006801:Humans; D037181:Lectins, C-Type / Q000378:metabolism; D010957:Plasmids; D011485:Protein Binding; D011971:Receptors, Immunologic / Q000378:metabolism; D051116:Receptors, Scavenger; D060225:Tetraspanin 28; D019444:Vaccines, DNA; D014759:Viral Envelope Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D014761:Viral Hepatitis Vaccines
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; C554798:CD81 protein, human; D037181:Lectins, C-Type; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; D060225:Tetraspanin 28; D019444:Vaccines, DNA; D014759:Viral Envelope Proteins; D014761:Viral Hepatitis Vaccines; C091015:glycoprotein E2, Hepatitis C virus